P&K Skin Research Center Co., Ltd. (KOSDAQ:347740)

Market Cap	68.59B +11.0%
Revenue (ttm)	22.78B +27.7%
Net Income	4.69B -19.4%
EPS	162.22 -19.0%
Shares Out	28.88M
PE Ratio	14.64
Forward PE	n/a
Dividend	50.00 (2.14%)
Ex-Dividend Date	Dec 29, 2025

Volume	181,518
Average Volume	143,936
Open	2,335.00
Previous Close	2,335.00
Day's Range	2,285.00 - 2,415.00
52-Week Range	1,996.00 - 3,300.00
Beta	0.88
RSI	46.04
Earnings Date	May 15, 2026

About P&K Skin Research Center

P&K Skin Research Center Co., Ltd. engages in the evaluation and research of dermatological products in South Korea. It provides scientific information and technical support services for new cosmetic raw material development, functional cosmetics, and human application testing of quasi-drugs. The company performs human application, safety, efficacy, cosmeceuticals, health food, sensory, and in vitro tests. It also manufactures and sells raw pharmaceutical and cosmetic materials, and raw materials for health foods. The company was founded in 201...

• Industry: Commercial Physical and Biological Research
• Founded: 2010
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 347740

Financial Performance

In 2025, P&K Skin Research Center's revenue was 22.78 billion, an increase of 27.66% compared to the previous year's 17.85 billion. Earnings were 4.69 billion, a decrease of -19.45%.